Designing vaccines to prevent breast cancer recurrence or invasive disease

Abstracts
2015
Immunotherapy
Stanton SE, Disis ML
Description / Abstract: 

Introduction: With the emerging importance of the tumor immune environment in both invasive and preinvasive breast cancer, vaccine therapy may provide a well-tolerated, durable therapy for preinvasive breast cancer by preventing both recurrent preinvasive disease and progression to invasive disease. Preinvasive breast cancer is ideal for vaccines because the disease is slow growing and the patients are not immunosuppressed. However, design of the vaccines are critical including consideration of appropriate antigens, selecting Th1 stimulating epitopes, and using multiantigen vaccines to address tumor heterogeneity.

PubMed ID: 
25713984